← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 30, 2019Last known activity
Nov 30, 2021
Timeline
1920s
- Jan 1, 1923
Institut Régional du Cancer de Montpellier— Founded
Drugs by trial phase (6 distinct, 3 trials)
Phase 2 (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05065801Study chairPhase 2Nov 30, 2021
- NCT04570943Study chairPhase 2Dec 15, 2020
- NCT04053322Overall official - principal investigatorPhase 2Sep 30, 2019
Details
- Founded
- Montpellier, FR Jan 1, 1923
- Last known activity
- Nov 30, 2021